Compare, Analyse Divis Laboratories with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ADCOCK INGRAM (S. Africa) - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DIVIS LABORATORIES   ADCOCK INGRAM
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-19
ADCOCK INGRAM
Jun-14
DIVIS LABORATORIES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,639331-   
Low Rs1,115239-   
Sales per share (Unadj.) Rs186.398.6-  
Earnings per share (Unadj.) Rs51.0-24.8-  
Cash flow per share (Unadj.) Rs57.3-20.6-  
Dividends per share (Unadj.) Rs16.000-  
Dividend yield (eoy) %1.20-  
Book value per share (Unadj.) Rs261.877.4-  
Shares outstanding (eoy) m265.47168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.42.9 255.5%   
Avg P/E ratio x27.0-11.5 -235.4%  
P/CF ratio (eoy) x24.0-13.9 -173.4%  
Price / Book Value ratio x5.33.7 142.7%  
Dividend payout %31.40-   
Avg Mkt Cap Rs m365,59248,131 759.6%   
No. of employees `00011.84.3 276.0%   
Total wages/salary Rs m5,4233,021 179.5%   
Avg. sales/employee Rs Th4,175.13,874.9 107.7%   
Avg. wages/employee Rs Th457.7703.7 65.1%   
Avg. net profit/employee Rs Th1,141.8-976.4 -116.9%   
INCOME DATA
Net Sales Rs m49,46316,635 297.3%  
Other income Rs m1,556116 1,336.0%   
Total revenues Rs m51,01916,751 304.6%   
Gross profit Rs m18,718-2,883 -649.3%  
Depreciation Rs m1,689718 235.3%   
Interest Rs m35451 7.8%   
Profit before tax Rs m18,551-3,935 -471.5%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,023246 2,043.1%   
Profit after tax Rs m13,527-4,192 -322.7%  
Gross profit margin %37.8-17.3 -218.4%  
Effective tax rate %27.1-6.2 -433.4%   
Net profit margin %27.3-25.2 -108.5%  
BALANCE SHEET DATA
Current assets Rs m46,50112,184 381.7%   
Current liabilities Rs m8,4686,855 123.5%   
Net working cap to sales %76.932.0 240.0%  
Current ratio x5.51.8 309.0%  
Inventory Days Days131111 117.9%  
Debtors Days Days86124 69.3%  
Net fixed assets Rs m25,7977,102 363.2%   
Share capital Rs m53177 687.4%   
"Free" reserves Rs m68,9620-   
Net worth Rs m69,49313,056 532.3%   
Long term debt Rs m04,588 0.0%   
Total assets Rs m80,38324,665 325.9%  
Interest coverage x531.0-7.7 -6,867.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 91.2%   
Return on assets %16.9-15.2 -111.2%  
Return on equity %19.5-32.1 -60.6%  
Return on capital %26.7-19.8 -135.0%  
Exports to sales %00-   
Imports to sales %24.60-   
Net fx Rs m28,8330-   
CASH FLOW
From Operations Rs m9,5431,420 672.1%  
From Investments Rs m-6,854-436 1,572.1%  
From Financial Activity Rs m-2,4594,164 -59.1%  
Net Cashflow Rs m2305,148 4.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.57 Rs / ZAR

Compare DIVIS LABORATORIES With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare DIVIS LABORATORIES With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  CADILA HEALTHCARE  JUBILANT LIFE SCIENCES  PFIZER  



Today's Market

Sensex Opens Lower Tracking Weak Global Cues; L&T Slips 4% Post Q2 Results(09:30 am)

Asian share markets are trading on a negative note today. The Nikkei is trading down by 0.7% and the Hang Seng is trading lower by 1%.

Related Views On News

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

PSU Banks Will Move Up Again (Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DIVIS LABORATORIES SHARE PRICE


Oct 29, 2020 10:08 AM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 5-YR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

FEATURED VIDEOS

The Real Upside in Kotak - IndusInd Bank Merger

Value Vs Growth Investing: And the Winner Is...

Why ITC and not HUL is my Idea of a Good Investment Right Now

Contrarian Trading in PSU Banks

More Featured Videos

MARKET STATS